Astrantus’s Abbott ABT Stock Holding History

Astrantus’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$473K	Buy	+4,000	New	+$496K	0.8%	10

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Astrantus's ABT Position: Q1 2022 in Review

Astrantus opened a new position in Abbott (ABT) in Q1 2022: 4,000 shares worth $473K. The stake represents 0.8% of the portfolio and ranks #10 among its holdings.

2,759 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

Astrantus held 4,000 shares of Abbott worth $473K as of Q1 2022.
Abbott was a new Astrantus position in Q1 2022.
Abbott made up 0.8% of Astrantus's portfolio in Q1 2022, its #10 holding.
2,759 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.